Search Results

There are 7854174 results for: content related to: Protein intake in Parkinsonian patients using the EPIC food frequency questionnaire

  1. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  2. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 30, Issue S1, June 2015, Pages: S1–S567,

    Version of Record online : 12 JUN 2015, DOI: 10.1002/mds.26295

  3. Poster Sessions: Clinical Science

    Movement Disorders

    Volume 21, Issue S13, January 2006, Pages: S81–S134,

    Version of Record online : 19 JAN 2006, DOI: 10.1002/mds.20871

  4. Abstracts of The Movement Disorder Society's Twelfth International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 23, Issue S1, 15 May 2008, Pages: S1–S422,

    Version of Record online : 28 MAY 2008, DOI: 10.1002/mds.22133

  5. Levodopa

    Movement Disorders

    Volume 17, Issue S4, July/August 2002, Pages: S23–S37,

    Version of Record online : 29 JUL 2002, DOI: 10.1002/mds.5558

  6. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Version of Record online : 6 JUN 2014, DOI: 10.1002/mds.25914

  7. Dyskinesia Induced by Levodopa and Dopamine Agonists in Patients with Parkinson's Disease

    Drug Induced Movement Disorders, Second Edition

    John G. Nutt, Matthew A. Brodsky, Pages: 313–350, 2008

    Published Online : 14 JAN 2008, DOI: 10.1002/9780470753217.ch13

  8. You have free access to this content
    Abstracts

    Movement Disorders

    Volume 32, Issue S2, June 2017, Pages: S1–S627,

    Version of Record online : 2 JUN 2017, DOI: 10.1002/mds.27087

  9. Low-protein and protein-redistribution diets for Parkinson's disease patients with motor fluctuations: A systematic review

    Movement Disorders

    Volume 25, Issue 13, 15 October 2010, Pages: 2021–2034, Emanuele Cereda, Michela Barichella, Carlo Pedrolli and Gianni Pezzoli

    Version of Record online : 28 JUL 2010, DOI: 10.1002/mds.23226

  10. You have free access to this content
    Abstracts of The Movement Disorder Society's Eleventh International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 22, Issue S16, 2007, Pages: S1–S325,

    Version of Record online : 24 APR 2007, DOI: 10.1002/mds.21535

  11. Poster session 2, Abstracts 345–694

    Movement Disorders

    Volume 19, Issue S9, 2004, Pages: S129–S244,

    Version of Record online : 10 MAY 2004, DOI: 10.1002/mds.20176

  12. You have free access to this content
    Poster Session

    Movement Disorders

    Volume 31, Issue S2, June 2016, Pages: S1–S697,

    Version of Record online : 19 JUN 2016, DOI: 10.1002/mds.26688

  13. Levodopa-induced dyskinesias in Parkinson's disease: Is sensitization reversible?

    Annals of Neurology

    Volume 47, Issue 5, May 2000, Pages: 655–658, Boulos-Paul Bejjani, Isabelle Arnulf, Sophie Demeret, Philippe Damier, Anne-Marie Bonnet, Jean-Luc Houeto and Yves Agid

    Version of Record online : 3 MAY 2001, DOI: 10.1002/1531-8249(200005)47:5<655::AID-ANA16>3.0.CO;2-#

  14. You have full text access to this OnlineOpen article
    Population pharmacokinetics of levodopa in subjects with advanced Parkinson's disease: levodopa-carbidopa intestinal gel infusion vs. oral tablets

    British Journal of Clinical Pharmacology

    Volume 78, Issue 1, July 2014, Pages: 94–105, Ahmed A. Othman and Sandeep Dutta

    Version of Record online : 20 JUN 2014, DOI: 10.1111/bcp.12324

  15. Adenosine A2A antagonism reverses levodopa-induced motor alterations in hemiparkinsonian rats

    Synapse

    Volume 46, Issue 4, 15 December 2002, Pages: 251–257, J. Bové, C. Marin, M. Bonastre and E. Tolosa

    Version of Record online : 4 OCT 2002, DOI: 10.1002/syn.10112

  16. Poster Session 3

    Movement Disorders

    Volume 21, Issue S15, September 2006, Pages: S517–S613,

    Version of Record online : 20 SEP 2006, DOI: 10.1002/mds.21248

  17. Poster session 1: A. Basic science, genetics, neuropharmacology, Parkinson's Disease

    Movement Disorders

    Volume 17, Issue S5, November 2002, Pages: S17–S64,

    Version of Record online : 21 OCT 2002, DOI: 10.1002/mds.10349

  18. Lack of Pharmacokinetic Interactions Between Transdermal Rotigotine and Oral Levodopa/Carbidopa

    The Journal of Clinical Pharmacology

    Volume 49, Issue 9, September 2009, Pages: 1047–1055, Marina Braun, Willi Cawello, Jens-Otto Andreas, Dipl Math, Hilmar Boekens and Rolf Horstmann

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009338481

  19. Treatment of levodopa-induced motor complications

    Movement Disorders

    Volume 23, Issue S3, 2008, Pages: S599–S612, Fabrizio Stocchi, Michele Tagliati and C. Warren Olanow

    Version of Record online : 9 SEP 2008, DOI: 10.1002/mds.22052

  20. Catechol-O-Methyltransferase (COMT) Inhibitors in Parkinson's Disease

    Journal of the American Geriatrics Society

    Volume 48, Issue 6, June 2000, Pages: 692–698, Cheryl Waters

    Version of Record online : 27 APR 2015, DOI: 10.1111/j.1532-5415.2000.tb04732.x